1 |
Brune, B., Knethen, A. V. and Sandau, K. B. 1998. Nitric oxide and its role in apoptosis. Eur J Pharmacol 351, 261-272.
DOI
ScienceOn
|
2 |
Ambs, S., Hussain, S. P., and Harris, C. C. 1997. Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression. FASEB J 11, 443-448.
DOI
|
3 |
Billiar, T. R., Curran, R. D., Harbrecht, B. G., Stuehr, D. J., Demetris, A. J. and Simmons, R. L. 1990. Modulation of nitrogen oxide synthesis in vivo: NG-monomethyl-L-arginine inhibits endotoxin-induced nitrate/nitrate biosynthesis while promoting hepatic damage. J Leukoc Biol 48, 565-569.
DOI
|
4 |
Bonavida, B., Khineche, S., Huerta-Yepez, S. and Garban, H. 2006. Therapeutic potential of nitric oxide in cancer. Drug Resist Updat 9, 157-173.
DOI
ScienceOn
|
5 |
De Boo, S., Kopecka, J., Brusa, D., Gazzano, E., Matera, L., Ghigo, D., Bosia, A. and Riganti, C. 2009. iNOS activity is necessary for the cytotoxic and immunogenic effects of doxorubicin in human colon cancer cells. Mol Cancer 8, 108-111.
DOI
ScienceOn
|
6 |
Deveraux, Q. L. and Reed, J. C. 1999. IAP family proteins--suppressors of apoptosis. Genes Dev 13, 239-252.
DOI
ScienceOn
|
7 |
Dunkern, T. R., Wedemeyer, I., Baumgärtner, M., Fritz, G. and Kaina, B. 2003. Resistance of p53 knockout cells to doxorubicin is related to reduced formation of DNA strand breaks rather than impaired apoptotic signaling. DNA Repair 2, 49-60.
DOI
ScienceOn
|
8 |
Green, L. C., Wagner, D. A., Glogowski, J., Skipper, P. L., Wishnok, J. S. and Tannenbaum, S. R. 1982. Analysis of nitrate, nitrite, and [15 N] nitrate in biological fluids. Anal Biochem 126, 131-138.
DOI
ScienceOn
|
9 |
Hartwell, L. H. and Kastan, M. B. 1994. Cell cycle control and cancer. Science 266, 1821-1828.
DOI
|
10 |
Huerta, S., Chilka, S. and Bonavida, B. 2008. Nitric oxide donors: novel cancer therapeutics (review). Int J Oncol 33, 909-927.
|
11 |
Krishan, A. 1975. Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J Cell Biol 66, 188-193.
DOI
ScienceOn
|
12 |
Jung, K. W., Park, S. H., Kong, H. J., Won, Y. J., Lee, J. Y., Park, E. C. and Lee, J. S. 2011. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2008. Cancer Res Treat 43, 1-11.
DOI
ScienceOn
|
13 |
Makin, G. and Dive, C. 2001. Apoptosis and cancer chemotherapy. Trends Cell Biol 11, S22-S26.
DOI
ScienceOn
|
14 |
Kalivendi, S. V., Kotamraju, S., Zhao, H., Joseph, J. and Kalyanaraman, B. 2001. Doxorubicin-induced apoptosis is associated with increased transcription of endothelial nitric- oxide synthase. Effect of antiapoptotic antioxidants and calcium. J Biol Chem 276, 47266-47276.
DOI
ScienceOn
|
15 |
Kim, J. H. and Kim, M. Y. 2014. Immature citrus fruit extracts enhance the apoptosis inducing potential of cisplatin in human malignant Melanoma A375 Cells via regulation of nitric oxide and inhibitor of apoptosis family (IAP). J Life Sci 24, 454-460.
DOI
ScienceOn
|
16 |
LaCasse, E. C., Baird, S., Korneluk, R. G. and MacKenzie, A. E. 1998. The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene 17, 3247-3259.
DOI
|
17 |
Makin, G. and Hickman, J. A. 2000. Apoptosis and cancer chemotherapy. Cell Tissue Res 301, 143-152.
DOI
ScienceOn
|
18 |
Minotti, G., Menna, P., Salvatorelli, E., Cairo, G. and Gianni, L. 2004. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev 56, 185-229.
DOI
ScienceOn
|
19 |
Mocellin, S., Bronte, V. and Nitti, D. 2007. Nitric oxide, a double edged sword in cancer biology: searching for therapeutic opportunities. Med Res Rev 27, 317-352.
DOI
ScienceOn
|
20 |
Nagata, S. 2000. Apoptotic DNA fragmentation. Exp Cell Res 256, 12-18.
DOI
ScienceOn
|
21 |
Park, E. J., Kwon, H. K., Choi, Y. M., Shin H. J., and Choi, S. D. 2012. Doxorubicin induces cytotoxicity through upregulation of perk-dependent ATF3. PloS One 7, e44990.
DOI
ScienceOn
|
22 |
Mojic, M., Mijatovic, S., Maksimovic-Ivanic, D., Miljkovic, D., Stosic-Grujicic, S., Stankovic, M., Mangano, K., Travali, S., Donia, M., Fagone, P., Zocca, M. B., Al-Abed, Y., McCubrey, J. A. and Nicoletti, F. 2012. Therapeutic potential of nitric oxide-modified drugs in colon cancer cells. Mol Pharmacol 82, 700-710.
DOI
|
23 |
Moncada, S. and Higgs, E. A. 1995. Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J 9, 1319-1330.
DOI
|
24 |
Murphy, M. P. 1999. Nitric oxide and cell death. Biochim Biophys Acta 1411, 401-414.
DOI
ScienceOn
|
25 |
Shah, G., Zhang, G., Chen, F., Cao, Y., Kalyanaraman, B. and See, W. A. 2014. iNOS expression and NO production contribute to the direct effects of BCG on urothelial carcinoma cell biology. Urol Oncol 32, 45.
|
26 |
Tang, N., Du, G., Wang, N., Liu, C., Hang, H. and Liang, W. 2007. Improving penetration in tumors with nanoassemblies of phospholipids and doxorubicin. J Natl Cancer Inst 99, 1004-1015.
DOI
ScienceOn
|
27 |
Tolnai, S. 1975. A method for viable cell count. Methods Cell Sci 1, 37-38.
|
28 |
Tsang, W. P., Chau, S. P. Y., Kong, S. K., Fung, K. P. and Kwok, T. T. 2003. Reactive oxygen species mediate doxorubicin induced p53-independent apoptosis. Life Sci 73, 2047-2058.
DOI
ScienceOn
|